While beyond the scope of the present study, future studies could manipulate IFNγ signaling to promote or limit microglial mobilization toward lesions associated with vascular injury or multiple sclerosis (76), and determine if they hold any therapeutic benefit. This evidence concerns the gene IFNG and multiple sclerosis.